ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 290

Characterization of Neutrophil Subsets and Neutrophil Extracellular Traps in Pyogenic Arthritis, Pyoderma Gangrenosum and Acne (PAPA) Syndrome

Pragnesh Mistry1, Carmelo Carmona-Rivera1, Nickie Seto1, Monica Purmalek1, Amanda Ombrello2, Ivona Aksentijevich2, Daniel L. Kastner2 and Mariana J. Kaplan1, 1Systemic Autoimmunity Branch, NIAMS/NIH, Bethesda, MD, 2Inflammatory Disease Section, NHGRI/NIH, Bethesda, MD

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Autoinflammatory Disease, Neutrophil Extracellular Traps and neutrophils

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Innate Immunity and Rheumatic Disease Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Pyogenic arthritis, pyoderma gangrenosum and acne (PAPA) syndrome is an autosomal dominant autoinflammatory disorder caused by mutations in the PSTPIP1/CD2BP1 gene. PAPA syndrome is characterized by recurrent flares of sterile arthritis and severe skin inflammation in the absence of adaptive immune responses. Mutations in PSTPIP1 likely dysregulate the pyrin inflammasome leading to exuberant IL-1β production. PAPA patients respond to treatment with cytokine inhibitors, including IL-1 inhibitors. Neutrophils can undergo a form of cell death called NETosis where dying cells release a meshwork of decondensed DNA decorated with granule proteins called neutrophil extracellular traps (NETs). NETs have been shown to induce tissue damage in other systemic diseases. While previous studies have suggested that neutrophils may play critical roles in driving inflammation in PAPA syndrome, the mechanism by which it happens is still unclear. A subset of proinflammatory neutrophils called low-density granulocytes (LDGs) has been identified in other autoimmune/autoinflammatory conditions and these cells display an enhanced capacity to form NETs. Here, we aimed to elucidate the role of neutrophil subsets and NETs in the pathogenesis of PAPA syndrome.

Methods: Normal density neutrophils were isolated by dextran sedimentation from control and PAPA patients. LDGs were isolated by negative selection from the PBMC fraction. Immunofluorescence (IF) was used to assess the presence of NETs. To assess the effect of serum in NET formation, control neutrophils were incubated with 10% serum from control or PAPA patients in the presence or absence of the IL-1 receptor anatagonist anakinra for 2 h. Circulating NET remnants were quantified by ELISA against citrullinated histone H3 (citH3)-DNA complexes. A skin biopsy from a PAPA patient was analyzed by IF, quantitative PCR, and western blot analysis for the presence of NETs and proinflammatory cytokines.

Results: LDGs were detected in PAPA patients. Neutrophils and LDGs from PAPA patients displayed an enhanced capacity to spontaneously form NETs when compared to control neutrophils. Serum from PAPA patients induced NET formation in control neutrophils and this process was inhibited in the presence of IL-1 inhibitor, anakinra. NET products, as measured by cit-H3-DNA complexes in plasma from PAPA patients, were significantly higher when compared to control plasma. We detected NETs in a skin biopsy from a PAPA patient, in association with upregulation of tissue IL-1β and IL-8 when compared to healthy skin biopsies. Furthermore, an immature granulocyte signature was detected in the skin biopsy tissue suggesting the presence of LDGs.

Conclusion: Taken together, neutrophils and LDGs in PAPA patients display dysregulated NET formation as assessed by in vitro spontaneous NET formation and the presence of circulating NET remnants. Proinflammatory cytokines in serum and affected tissues of PAPA patients trigger the NET formation. Anakinra ameliorates serum-induced NETosis, suggesting a role of IL-1 signaling in NETosis. The identification of LDGs in skin tissue from PAPA patients point out a strong myeloid signature in this condition.


Disclosure: P. Mistry, None; C. Carmona-Rivera, None; N. Seto, None; M. Purmalek, None; A. Ombrello, None; I. Aksentijevich, None; D. L. Kastner, None; M. J. Kaplan, None.

To cite this abstract in AMA style:

Mistry P, Carmona-Rivera C, Seto N, Purmalek M, Ombrello A, Aksentijevich I, Kastner DL, Kaplan MJ. Characterization of Neutrophil Subsets and Neutrophil Extracellular Traps in Pyogenic Arthritis, Pyoderma Gangrenosum and Acne (PAPA) Syndrome [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/characterization-of-neutrophil-subsets-and-neutrophil-extracellular-traps-in-pyogenic-arthritis-pyoderma-gangrenosum-and-acne-papa-syndrome/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/characterization-of-neutrophil-subsets-and-neutrophil-extracellular-traps-in-pyogenic-arthritis-pyoderma-gangrenosum-and-acne-papa-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology